Latest News about RHHBY
Recent news which mentions RHHBY
From Benzinga
From InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
From Motley Fool
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
From Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
From Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
From Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
From Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
From Benzinga
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
August 30, 2023
From Benzinga
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
From InvestorPlace
From Benzinga
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
August 23, 2023
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
What's Going On With Sonnet BioTherapeutics Stock Today?
August 16, 2023
From Benzinga
Is TTOO Stock Really Worth $5? Or Just 5 Cents?
August 09, 2023
From InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
From Motley Fool
Why Is Aravive Stock Sinking Today?
August 03, 2023
From Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
From Benzinga
From Benzinga
From Benzinga
Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy
July 24, 2023
From Benzinga
Why Novartis Stock Spiked Today
July 18, 2023
From Motley Fool
2 Nasdaq Stocks That Could Soar This Week
July 16, 2023
From Motley Fool